Literature DB >> 1547802

Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease.

E Lantto1, K Järvi, I Krekelä, T Lantto, M Taavitsainen, H Vedenkangas, M Vorne.   

Abstract

The inflammatory activity in 108 bowel segments of 40 patients with suspected or known inflammatory bowel disease was assessed macroscopically by endoscopy, histology and technetium-99m hexamethyl propylene amine oxine (99mTc-HMPAO) leucocytes using a numerical grading system (scores 0-3). A 4-h series of scintigrams showed a significant correlation with both histological and macroscopical assessment of disease activity (rho = 0.850, P less than 0.001 and rho = 0.773, P less than 0.001, respectively). Sensitivity, specificity and accuracy of scintigraphy in detecting active inflammatory segments were 85%, 92% and 89%, respectively. A normal scintigram did not completely exclude mild inflammatory activity, especially in the rectosigmoid area. 99mTc-HMPAO leucocytes offer an accurate and non-invasive alternative for the assessment of disease activity in ulcerative colitis and Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547802     DOI: 10.1007/bf00178302

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  13 in total

1.  Comparison of technetium-99m-HM-PAO leukocytes with indium-111-oxine leukocytes for localizing intraabdominal sepsis.

Authors:  P J Mountford; A G Kettle; M J O'Doherty; A J Coakley
Journal:  J Nucl Med       Date:  1990-03       Impact factor: 10.057

2.  Intestinal accumulation of 111In-granulocytes in patients studied because of occult infection.

Authors:  M T Syrjälä; K Liewendahl; V Valtonen; J Gripenberg
Journal:  Eur J Nucl Med       Date:  1987

3.  Extent of inflammatory lesions in ulcerative colitis assessed by radiology, colonoscopy, and endoscopic biopsies.

Authors:  N Gabrielsson; S Granqvist; P Sundelin; T Thorgeirsson
Journal:  Gastrointest Radiol       Date:  1979-11-15

Review 4.  Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications.

Authors:  W Becker; W Fischbach; M Weppler; B Mosl; G Jacoby; W Börner
Journal:  Nucl Med Commun       Date:  1988-10       Impact factor: 1.690

5.  Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease.

Authors:  R A Allan; G E Sladen; S Bassingham; C Lazarus; S E Clarke; I Fogelman
Journal:  Eur J Nucl Med       Date:  1993-03

6.  Indium-111 autologous leucocyte scanning: comparison with radiology for imaging the colon in inflammatory bowel disease.

Authors:  S H Saverymuttu; A M Peters; H J Hodgson; V S Chadwick; J P Lavender
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24

Review 7.  Advances in the assessment of disease activity in inflammatory bowel disease.

Authors:  M Camilleri; M Proano
Journal:  Mayo Clin Proc       Date:  1989-07       Impact factor: 7.616

8.  Comparison of 99Tcm-HMPAO and 111In-oxine labelled granulocytes in man: first clinical results.

Authors:  W Becker; E Schomann; W Fischbach; W Börner; K R Gruner
Journal:  Nucl Med Commun       Date:  1988-06       Impact factor: 1.690

9.  Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.

Authors:  J Schölmerich; E Schmidt; C Schümichen; P Billmann; H Schmidt; W Gerok
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

10.  Technetium-99m HM-PAO-labeled leukocytes in detection of inflammatory lesions: comparison with gallium-67 citrate.

Authors:  M Vorne; I Soini; T Lantto; S Paakkinen
Journal:  J Nucl Med       Date:  1989-08       Impact factor: 10.057

View more
  15 in total

1.  White cell scanning has a role in imaging small and large bowel.

Authors:  A P Poullis
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

2.  Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes.

Authors:  J W Arndt; M I Grootscholten; R A van Hogezand; G Griffioen; C B Lamers; E K Pauwels
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

3.  Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease.

Authors:  M Papós; F Nagy; J Láng; L Csernay
Journal:  Eur J Nucl Med       Date:  1993-09

4.  Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications.

Authors:  M H Giaffer
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

5.  Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT).

Authors:  M J Weldon; A M Masoomi; A J Britten; J Gane; C J Finlayson; A E Joseph; J D Maxwell
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

6.  Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease.

Authors:  M Sans; D Fuster; J Llach; F Lomeña; J M Bordas; R Herranz; J M Piqué; J Panés
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

Review 7.  Technetium leukocyte imaging in inflammatory bowel disease.

Authors:  M Charron
Journal:  Curr Gastroenterol Rep       Date:  1999-06

8.  Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative findings.

Authors:  J J Kolkman; T H Falke; J C Roos; D H Van Dijk; I M Bannink; W Den Hollander; M A Cuesta; A S Peña; S G Meuwissen
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

9.  PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine.

Authors:  Chandan Jyoti Das; Govind Makharia; Rakesh Kumar; Madhavi Chawla; Pooja Goswami; Raju Sharma; Arun Malhotra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-21       Impact factor: 9.236

10.  Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease.

Authors:  J C Alonso; F J Lopez-Longo; J L Lampreave; C M González; O Vegazo; L Carreño; I Almoguera
Journal:  Eur J Nucl Med       Date:  1996-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.